Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a disorder of consciousness, assessed using a recognised international standard tool called the CRS-R (a structured observation scale used by clinicians)
- People who are more than 28 days past the injury that caused their condition
- People who are taking psychiatric or neurological medications, provided that medication routine has been stable for at least 4 weeks before joining the study and is expected to stay the same throughout the trial
- People who have a legally authorised representative (such as a family member or guardian) available to give consent on their behalf
Who may not be able to join:
- People who have a history of a neurological condition other than the brain injury that caused their current condition
- People who have a metal implant in their body, or any other condition that would make it unsafe for them to be in an MRI scanner
- People who have continuous, ongoing involuntary movements that would make safe or successful brain imaging not possible
- People who are already taking part in another clinical trial at the same time
- People who require a machine to help them breathe (mechanical ventilation)
- People who have had a craniotomy where the bone has not been replaced (sometimes called a missing bone flap) (confirm with trial site)
- People who have had a cranioplasty (a surgical repair to the skull) that covers the left temporal area of the skull
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Martin M Monti, PhD, University of California, Los Angeles
Phone: 310-825-8546
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Establish short-term efficacy of tFUS as a therapeutic to promote recovery in patients with prolonged DoC as compared to sham treatment.; Establish dose-related safety and efficacy of tFUS as a therapeutic intervention in prolonged DoC patients.; Explore preliminary predictors and biomarkers of susceptibility and response to thalamic sonication.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.